CEDUR — German inflammatory bowel disease registry

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

CEDUR is a multicenter, web-based, prospective registry enrolling adult patients with Crohn's disease, ulcerative colitis, or indeterminate colitis across Germany. Physicians and patients provide clinical data, quality-of-life measures, treatment patterns, and safety outcomes during routine care. The registry also captures pharmacoeconomic information to study cost and resource use over time. Aggregated data are used to monitor care quality and long-term therapy outcomes under real-world conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Crohn Disease Ulcerative Colitis Indterminate Colitis

Exclusion Criteria:

* Other gastrointestinal disorders than above

Where it's running

• ImmunoRegister gUG
  Hamburg, Germany Recruiting

Study contacts

• Principal investigator: Stefanie Howaldt, MD — ImmunoRegister gUG
• Study coordinator: Stefanie Howaldt, MD
• Email: Howaldt@immunoregister.de
• Phone: +4940423265150

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• SMART-IBD app for teens with inflammatory bowel disease

  This will test whether the SMART-IBD smartphone app helps adolescents ages 13–17 with IBD take their medicines and manage symptoms better than completing daily diaries alone.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07195123

• Familial IBD Early Risk

  This study tests whether clinical, environmental, and immune factors in first-degree relatives of people with Crohn’s disease or ulcerative colitis can predict who will develop IBD.

  Recruiting Seattle Children's Hospital · Seattle, Washington · NCT07791862

• Biomarker Discovery and Validation Platform for Inflammatory Bowel Disease

  Researchers are testing biomarker models to see if they can measure and predict inflammation and treatment response in people with Crohn's disease, ulcerative colitis, or related IBD.

  Recruiting Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong and 1 other locations · NCT07686406

• Wearable data to spot IBD flareups in people with ulcerative colitis or Crohn's disease

  This study tests whether heart‑rate variability from participants’ own wearables can help predict IBD flares.

  Recruiting at 2 sites Maastricht University Medical Center · 's-Hertogenbosch and 2 other locations · NCT07647640

• Individualizing Anti-TNF Therapy in IBD

  This study tests whether genetic markers can predict which anti-TNF–naïve IBD patients will respond to their first anti-TNF treatment.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT07644117

• LRG levels and IBD activity in European patients

  This study will test whether Leucine-rich α2-glycoprotein (LRG) levels reflect disease activity in adults with Crohn’s or ulcerative colitis who are undergoing routine endoscopy in Europe.

  Recruiting Imelda GI Clinical Research Center · Bonheiden · NCT07621783

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.